QA: Merus N.V. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001651311_2021_Merus_N_V.pdf

Logs

warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': inf, 'aggregate_val': 29943000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}}

Graph

Absolute values for 0001651311, Merus N.V.

  xvar xval
0 AssetsCurrent 217,993,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 4,115,000
3 remainder_Assets 9,109,000
4 LiabilitiesCurrent 46,746,000
5 LiabilitiesNoncurrent 2,521,000
6 remainder_Liabilities 79,687,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 35,781,000
9 ResearchAndDevelopmentExpense 70,040,000
10 remainder_Expenses 503,000
11 remainder_Revenues 29,943,000
12 remainder_NetIncome -9,132,000
13 remainder_ComprehensiveNetIncome 7,485,000
  yvar yval
0 Assets 231,217,000
1 Liabilities 128,954,000
2 Expenses 106,324,000
3 Revenues 29,943,000
4 StockholdersEquity 102,263,000
5 NetIncome -85,513,000
6 ComprehensiveNetIncome -81,770,500
7 BaseVar 256,527,500
8 EconomicCapitalRatio 0.523

Edgar->Model Mapping

Feature Distribution

Change over Time